Differences in plasma TIMP-1 levels between healthy people and patients with rectal cancer stage II or III

Pesta M, Topolcan O, Holubec L, Rupert K, Cerna M, Holubec L, et al. Clinicopathological assesment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples. Anticancer Res 2007; 27: 1863-8.Search in Google Scholar

Li M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y. Role of matrix metaloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth and angiogenesis. Exp Biol Med 2006; 231: 20-7.10.1177/15353702062310010316380641Search in Google Scholar

Giaginis C, Nikiteas N, Margeli A, Tzanakis N, Rallis G, Kouraklis G, et al. Serum tissue inhibitor of metalloproteinase 1 and 2 (TIMP-1 and TIMP-2) levels in colorectal cancer patients: association with clinicopathological variables and patients survival. Int J Biol Markers 2009; 24: 245-52.10.1177/172460080902400405Search in Google Scholar

Alo-Aho R, Kahari VM. Colagenases in cancer. Biochemie 2005; 87: 273-86.10.1016/j.biochi.2004.12.00915781314Search in Google Scholar

Sørensen NM, Sørensen IV, Wűrtz SØ, Schrohl AS, Dowell B, Davis G, et al. Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment. Scan J Gastroenterol 2008; 43: 774-86.10.1080/0036552070187816318584515Search in Google Scholar

Frederiksen CB, Lomholt AF, Lottenburger T, Davis GJ, Dowell BL, Blankenstein MA, et al. Assesment of the biological variation of plasma tissue inhibitor of metalloproteinase-1. Int J Biol Markers 2008; 23: 42-7.10.1177/172460080802300107Search in Google Scholar

Horvat M, Stabuc B. Microsatellite instability in colorectal cancer. Radiol Oncol 2011; 45: 75-81.10.2478/v10019-011-0005-8342372922933939Search in Google Scholar

Yaolin Zhou Y, Boardman LA, Miller RC. Genetic testing for young-onset colorectal cancer: case report and evidence-based clinical guidelines. Radiol Oncol 2010; 44: 57-61.Search in Google Scholar

Wass ET, Hendriks T, Lomme RM, Woblles T. Plasma levels of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-1 correlate with disease stage and survival in colorectal cancer patients. Dis Colon Rectum 2005; 48: 700-10.10.1007/s10350-004-0854-y15906450Search in Google Scholar

Kahlert C, Bandapalli OR, Schirmacher P, Weitz J, Brand K. Invasion front-specific overexpression of tissue inhibitor of metalloproteinase-1 in liver metastases from colorectal cancer. Anticancer Res 2008; 28: 1459-66.Search in Google Scholar

Holten-Andersen MN, Murphy G, Nielsen HJ, Pedersen AN, Christensen IJ, Høyer-Hansen G, et al. Quantitation of TIMP-1 in plasma of healthy blood donors and patients with advanced cancer. Br J Cancer 1999; 80: 495-503.10.1038/sj.bjc.6690384236230910408859Search in Google Scholar

Hammer JH, Basse L, Svendsen MN, Werther K, Brüner N, Christensen IJ, et al. Impact of elective resection on plasma TIMP-1 in patients with colon cancer. Colorectal Dis 2006; 8: 168-72.10.1111/j.1463-1318.2005.00831.x16466554Search in Google Scholar

Holten-Andersen MN, Christensen IJ, Nielsen HJ, Stephens RW, Jensen V, Nielsen OH, et al. Total levels of tissue inhibitor of metalloproteinases 1 in plasma yield high diagnostic sensitivity and specificity in patients with colon cancer. Clin Cancer Res 2002; 8: 156-64.Search in Google Scholar

Holten-Andersen MN, Stephens RW, Nielsen HJ, Murphy G, Christensen IJ, Stetler-Stevenson W, et al. High preoperative plasma tissue inhibitor of metalloproteinase-1 levels are associated with short survival of patients with colorectal cancer. Clin Cancer Res 2000; 6: 4292-9.Search in Google Scholar

Sofic A, Beslic S, Kocijancic I, Sehovic N. CT colonography in detection of colorectal carcinoma. Radiol Oncol 2010; 44: 19-23.10.2478/v10019-010-0012-1342367622933886Search in Google Scholar

Oblak I, Petric P, Anderluh F, Velenik V, Hudej R, Fras AP. Anal cancer chemoirradiation with curative intent - a single institution experience. Neoplasma 2009; 56: 150-5.10.4149/neo_2009_02_15019239330Search in Google Scholar

Ishida H, Murata N, Hayashi Y, Tada M, Hashimoto D. Serum levels of tissue inhibitor of metalloproteinases-1 (TIMP-1) in colorectal cancer patients. Surg Today 2003; 33: 885-92.10.1007/s00595-003-2628-x14669077Search in Google Scholar

Tayebjee MH, Lip GYH, Blann AD, MacFadyen RJ. Effects of age, gender, ethnicity, diurnal variations and exercise on circulating levels of matrix metalloproteinases (MMP)-2 and -9, and their inhibitors, tissue inhibitors of matrix metalloproteinases (TIMP)-1 and -2. Thromb Res 2005; 115: 205-10.10.1016/j.thromres.2004.08.02315617743Search in Google Scholar